This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:

 For an Aggregate of ~$14B, BMS Acquires Karuna Therapeutics

Read More: BMS & Karuna Therapeutics                                                

 For an Aggregate of ~$1.2B, AstraZeneca to Acquire Gracel Biotechnology

Read More: AstraZeneca & Gracel Biotechnology                                  

For an Aggregate of ~$4.1B, BMS to Acquire RayzeBio

Read More: BMS & RayzeBio                                                                 

Crossject Enters into a Collaboration Agreement with its Strategic Partner to Commercialize Zepizure Across Europe for Epileptic Seizures

Read More: Crossject                                                                               

 For an Aggregate of ~$70M, Polaris Group Acquires Genovior Biotech 

Read More: Polaris Group & Genovior Biotech                                            

LegoChem Signs a Collaboration Agreement with Janssen Biotech to Develop and Commercialize LCB84 Trop2-Targeted ADC

Read More:  LegoChem & Janssen Biotech                                            

Innovent Signs a Collaboration Agreement with SanegeneBio to Develop SGB-3908 for the Treatment of Hypertension

Read More: Innovent & SanegeneBio                                                   

Innovent Biologics Sings a Collaboration Agreement with Xuanzhu Biopharma to Study and Supply Tyvyt with KM-501 for Solid Tumors

Read More: Innovent Biologics & Xuanzhu Biopharma                           

Codexis and Nestlé Health Science Collaborate to Develop CDX-7108 for Treating Exocrine Pancreatic Insufficiency (EPI)

Read More: Codexis & Nestlé Health Science                                        

Astellas Sings Research Collaboration and License Agreement with Elpiscience to Develop Bispecific Macrophage Engagers to Treat Cancer

Read More: Astellas & Elpiscience                                                      

Hi-Tech Pharmaceuticals Reports Launch of Slimaglutide

Read More: Hi-Tech Pharmaceuticals                                                    

Tyra Biosciences Highlights the Clinical Trial Updates for TYRA-200 and TYRA-300 to Treat Solid Tumors

Read More: Tyra Biosciences                                                                        

Amylyx Pharmaceuticals Reports the First Patient Dosing in P-III Trial of AMX0035 to Treat Progressive Supranuclear Palsy (PSP)

Read More: Amylyx Pharmaceuticals                                                           

Merck and Daiichi Sankyo Reports the US FDA’s Acceptance of BLA for HER3-DXd and Receives Priority Review for the Treatment of Non Small Cell Lung Cancer 

Read More: Merck and Daiichi Sankyo                                                        

Hyloris Highlights the Clinical Data for Valacyclovir Oral Suspension to Treat Herpes Virus Infections

Read More: Hyloris                                                                                         

Kuros Biosciences Highlights the Results from Two Clinical Trials in Patients with Degenerative Disc Disease (DDD)

Read More: Kuros Biosciences                                                                      

Cytokinetics Reveals P-III (SEQUOIA-HCM) Study Results of Aficamten for Obstructive Hypertrophic Cardiomyopathy

Read More: Cytokinetics                                                                              

Jiangsu Recbio Technology Reports Interim Analysis Data from the Study of REC610 for Shingles Conducted in the Philippines

Read More: Jiangsu Recbio Technology                                                      

NKGen Biotech Reports First Patient Dosing with SNK01 in P-I/IIa Study for Treating Moderate Alzheimer’s Disease

Read More: NKGen Biotech                                                                           

Boston Scientific Commences (AVANT GUARD) Study of Farapulse Pulsed Field Ablation System as a 1L Treatment for Persistent Atrial Fibrillation (AF)

Read More: Boston Scientific                                                                     

BeiGene Receives the US FDA’s Approval to Update Label for Brukinsa to Include Chronic Lymphocytic Leukemia 

Read More: BeiGene                                                                                  

Zealand Pharma Reports NDA Submission for Glepaglutide to the US FDA for the Treatment of Short Bowel Syndrome (SBS)

Read More: Zealand Pharma                                                                     

The US FDA Cleared Senti Bio’s IND Application for SENTI-202 to Treat Hematologic Malignancies

Read More: Senti Bio                                                                                  

The EMA Approves Cidara Therapeutics’ Rezzayo for the Treatment of Invasive Candidiasis

Read More: Cidara Therapeutics                                                                

The TGA Approve Asieris’ Application to Initiate P-I Trial APL-2301 to Treat Acinetobacter baumannii Infection

Read More: Asieris                                                                                      

The US FDA Approves CVRx’s Label Expansion for Barostim

Read More: CVRx                                                                                       

The Taiwan FDA Accepts Everest Medicines’ NDA for Nefecon to Treat Primary IgA Nephropathy

Read More: Everest Medicines                                                                

Sequana Medical Submits a Premarket Approval Application to the US FDA for alfapump to Treat Ascites due to Liver Cirrhosis 

Read More: Sequana Medical                                                             

CytoSorbents Reports Initial Data Analysis from the STAR-T Study of DrugSorb-ATR to Reduce Perioperative Bleeding

Read More: CytoSorbents                                                                           

Vivesto Reports Approval of the US Clinical Paccal Vet Study in Dogs with Splenic Hemangiosarcoma

Read More: Vivesto         

Related Post:- PharmaShots Weekly Snapshots (December 18 – December 22, 2023)